Commonly used metabolic labels for DNA, including 5-ethynyl-2′-deoxyuridine (EdU) and BrdU, are toxic antimetabolites that cause DNA instability, necrosis, and cell-cycle arrest. In addition to perturbing biological function, these properties can prevent metabolic labeling studies where subsequent tissue survival is needed. To bypass the metabolic pathways responsible for toxicity, while maintaining the ability to be metabolically incorporated into DNA, we synthesized and evaluated a small family of arabinofuranosylethynyluracil derivatives. Among these, (2′S)-2′-deoxy-2′-fluoro-5-ethynyluridine (F-ara-EdU) exhibited selective DNA labeling, yet had a minimal impact on genome function in diverse tissue types. Metabolic incorporation of F-ara-EdU into DNA was readily detectable using copper(I)-catalyzed azide-alkyne "click" reactions with fluorescent azides. F-ara-EdU is less toxic than both BrdU and EdU, and it can be detected with greater sensitivity in experiments where long-term cell survival and/or deep-tissue imaging are desired. In contrast to previously reported 2′-arabino modified nucleosides and EdU, F-ara-EdU causes little or no cellular arrest or DNA synthesis inhibition. F-ara-EdU is therefore ideally suited for pulse-chase experiments aimed at "birth dating" DNA in vivo. As a demonstration, Zebrafish embryos were microinjected with F-ara-EdU at the one-cell stage and chased by BrdU at 10 h after fertilization. Following 3 d of development, complex patterns of quiescent/senescent cells containing only F-ara-EdU were observed in larvae along the dorsal side of the notochord and epithelia. Arabinosyl nucleoside derivatives therefore provide unique and effective means to introduce bioorthogonal functional groups into DNA for diverse applications in basic research, biotechnology, and drug discovery. T he utilization of chemical techniques to address biological systems is becoming increasingly important in basic research and modern drug discovery (1). One underexplored area at the biology-chemistry interface is the study of nucleic acids in their native environments. Traditional DNA and RNA imaging methodologies have utilized fluorescent fusion proteins, nonspecific stains for nucleic acids, immunostaining of BrdU-labeled DNA, or FISH (2). All of these approaches are limited in terms of their low throughput, large perturbations to native systems, and/or inability to be applied in unmodified cells and organisms.
Commonly used metabolic labels for DNA, including 5-ethynyl-2′-deoxyuridine (EdU) and BrdU, are toxic antimetabolites that cause DNA instability, necrosis, and cell-cycle arrest. In addition to perturbing biological function, these properties can prevent metabolic labeling studies where subsequent tissue survival is needed. To bypass the metabolic pathways responsible for toxicity, while maintaining the ability to be metabolically incorporated into DNA, we synthesized and evaluated a small family of arabinofuranosylethynyluracil derivatives. Among these, (2′S)-2′-deoxy-2′-fluoro-5-ethynyluridine (F-ara-EdU) exhibited selective DNA labeling, yet had a minimal impact on genome function in diverse tissue types. Metabolic incorporation of F-ara-EdU into DNA was readily detectable using copper(I)-catalyzed azide-alkyne "click" reactions with fluorescent azides. F-ara-EdU is less toxic than both BrdU and EdU, and it can be detected with greater sensitivity in experiments where long-term cell survival and/or deep-tissue imaging are desired. In contrast to previously reported 2′-arabino modified nucleosides and EdU, F-ara-EdU causes little or no cellular arrest or DNA synthesis inhibition. F-ara-EdU is therefore ideally suited for pulse-chase experiments aimed at "birth dating" DNA in vivo. As a demonstration, Zebrafish embryos were microinjected with F-ara-EdU at the one-cell stage and chased by BrdU at 10 h after fertilization. Following 3 d of development, complex patterns of quiescent/senescent cells containing only F-ara-EdU were observed in larvae along the dorsal side of the notochord and epithelia. Arabinosyl nucleoside derivatives therefore provide unique and effective means to introduce bioorthogonal functional groups into DNA for diverse applications in basic research, biotechnology, and drug discovery. T he utilization of chemical techniques to address biological systems is becoming increasingly important in basic research and modern drug discovery (1) . One underexplored area at the biology-chemistry interface is the study of nucleic acids in their native environments. Traditional DNA and RNA imaging methodologies have utilized fluorescent fusion proteins, nonspecific stains for nucleic acids, immunostaining of BrdU-labeled DNA, or FISH (2) . All of these approaches are limited in terms of their low throughput, large perturbations to native systems, and/or inability to be applied in unmodified cells and organisms.
Metabolic labeling of DNA has traditionally been performed using [ 3 H]thymidine or BrdU. These labels are limited in terms of their subsequent visualization, requiring either autoradiography, or DNA denaturation and antibody staining (3). BrdU immunostaining is currently the most commonly used method, but it requires harsh chemical denaturation of cellular DNA and is limited by the poor tissue penetration of the BrdU antibody. In addition, BrdU itself is both toxic and mutagenic when applied at high concentrations, and it can have a negative impact on DNA stability and the cell cycle (4) .
The recent emergence of bioorthogonal chemical reporter strategies has revolutionized the study of biological macromolecules in their native environments (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . In this two-step approach, a synthetic label containing a bioorthogonal functional group is metabolically incorporated into the cellular target and subsequently probed using a chemoselective reaction. Importantly, only a small modification like an azide or a terminal alkyne is initially introduced, rendering the structure and function of the biomolecule virtually unchanged (5, 6) . The most commonly used chemoselective reactions for probe conjugation include the Staudinger ligation (7), copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) (8) , and strain-promoted azide-alkyne cycloaddition reactions (9, 10) . These reactions have been used to selectively label cellular proteins (11, 12) , polynucleotides (13, 14) , lipids (15, 16) , and glycans (17) (18) (19) in living cells and animals.
A strategy for the bioorthogonal chemical labeling of DNA was recently reported using the deoxythymidine analog 5-ethynyl-2′-deoxyuridine (EdU) (13, 20, 21) . After its metabolic incorporation into DNA by living cells, the ethynyl groups of EdU could be visualized with high sensitivity following CuAAC staining with fluorescent azides (13) . Unlike BrdU, this method does not require sample fixation or DNA denaturation prior to detection, and the sensitivity of EdU detection can exceed the limits of classical BrdU detection (22) . Despite these advantages, EdU is much more toxic than BrdU, and its use over prolonged experimental times results in highly nonuniform CuAAC staining due to cell-cycle arrest (22) (23) (24) (25) (26) (27) . In 2008, this EdU-based labeling strategy was commercialized by Invitrogen and subsequently used in cell proliferation and differentiation studies (28) , for measuring nucleotide excision repair activity (29) , for the analysis of nuclear architecture (30) , in tissue regeneration studies (31) , for cell-cycle analysis (32, 33) , and in at least 100 other published studies to date.
Despite its rapidly growing popularity, EdU is a highly toxic antimetabolite that perturbs DNA function and stability (22) (23) (24) 34) . The EdU inhibitory concentrations for cellular growth (IC 50 ¼ 0.2-4 μM) and G 2 ∕M cell-cycle arrest (IC 50 ¼ 0.2 μM) (22, (25) (26) (27) are approximately 50-fold lower than those required for efficient DNA labeling and detection (10 μM) (13, (28) (29) (30) (31) (32) (33) . In addition to perturbing biological function in complex ways, these properties complicate or even prevent metabolic labeling studies where subsequent tissue survival is needed. We speculated that nucleoside derivatives having a D-arabinose (ara) configuration might bypass the pathways responsible for the antimetabolic activities of EdU, BrdU, and other deoxyribosyl nucleoside derivatives. According to previous studies, however, the metabolic incorporation of arabinosyl nucleoside analogs such as cytosine arabinonucleoside, 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU), or 9-(β-D-arabinofuranosyl)-2-fluoroadenine (Fara-A) into DNA resulted in subsequent inhibition of DNA synthesis, eventually resulting in cell death by apoptosis (35) (36) (37) . It was therefore not clear a priori if an alkyne-modified arabinosyl nucleoside could exhibit efficient labeling of cellular DNA with-out inhibiting cellular proliferation. Given the overriding importance of genomic integrity, these properties may have been diametrically opposed by nature.
Here we report the design, synthesis, and evaluation of a small family of 2′-arabino-modified 5-ethynyluridine derivatives. Among these, (2′S)-2′-deoxy-2′-fluoro-5-ethynyluridine (F-ara-EdU) exhibited selective DNA labeling, yet has a minimal impact on genome function in diverse tissue types-including human, monkey, and mouse. Surprisingly, little or no cellular arrest or DNA synthesis inhibition was observed following the incorporation of F-araEdU into DNA. It is therefore compatible with both long-term and preparative labeling experiments of 60 d (or more) with constant feeding of the label. These results provide direct evidence that alkyne-containing nucleosides can be incorporated into cellular genomes that remain replication competent. In addition to enabling strategies in macromolecular engineering and drug discovery, arabinosyl nucleoside analogs can provide improved metabolic labels for applications involving bioorthogonal chemical reporter strategies. For example, F-ara-EdU is less toxic than both BrdU and EdU, and it can be detected with greater sensitivity in experiments where long-term cell survival and/or deep-tissue imaging are needed. F-ara-EdU is also fully compatible with BrdU in pulsechase experiments for birth dating of DNA in vivo. As a demonstration of this technique, Zebrafish embryos were microinjected with F-ara-EdU at the one-cell stage, followed by a BrdU "chase" at 5 or 10 h postfertilization (hpf). At 72 hpf, the embryos were fixed and stained. Excellent colocalization of F-ara-EdU and BrdU was observed when the BrdU chase was applied at end of blastula stage (5 hpf), whereas much less colocalization was observed in embryos chased with BrdU at the end of the gastrula stage (10 hpf). In the latter case, complex patterns of quiescent/ senescent cells containing only F-ara-EdU were observed along the dorsal side of the notochord and epithelia. These observations are consistent with the known timing of tissue development and differentiation in Zebrafish embryos (38, 39) , and furnish highresolution imaging of metabolically dated DNA in whole animals. Arabinosyl nucleoside derivatives therefore provide unique and effective means to introduce bioorthogonal functional groups into DNA in vivo. Due to its minimal impact on cellular proliferation and its persistence in labeled chromosomes, F-ara-EdU will expand the dynamic range of DNA labeling experiments in basic research, biotechnology, and drug discovery.
Results
Design of 5-Ethynyl-Arabino-Uridine Derivatives with Minimal Cytotoxic Activities. Despite the rapidly growing utilization of EdU in cell-based assays (13, (28) (29) (30) (31) (32) (33) , the mechanisms responsible for its potent cytotoxicity are highly diverse and only partially recognized (22, 24) . EdU is known to inhibit a variety of enzymes involved in nucleoside metabolism (24, 40, 41) , whereas its ability to cause cell-cycle arrest is presumably mediated by DNA damage response mechanisms that regulate the G 2 ∕M checkpoint (22, 42) . Depending upon the cell type, EdU can cause mutagenic and genotoxic effects including sister chromatid exchange (23), cell-cycle arrest resulting in necrosis (22) , and the inhibition of virus replication (25) . Taken together, these results suggest that EdU is capable of interacting with a wide variety of endogenous receptors, including nucleoside metabolizing enzymes and DNA binding proteins that specifically recognize the deoxyribose moiety. This type of promiscuity is not surprising, because the structure of EdU is nearly identical to its natural counterpart deoxyribosyl-thymine (dT). We reasoned that nucleoside and nucleotide derivatives having a D-arabinosyl (2′S) configuration should be capable of bypassing many of the metabolic pathways that recognize deoxyribosyl moieties. Previous studies have shown that substituents at the 2′(S) position can have a modulating effect on the antimetabolic activities of certain nucleoside derivatives (25) , but it was not known a priori if any alkynyl nucleoside (arabinofuranosyl or otherwise) could be incorporated into cellular DNA at detectable levels without having a negative impact on cellular proliferation. To test this possibility, we synthesized a small family of 5-ethynyl-arabinouridine derivatives containing Me, OH, or F at the 2′(S) position ( Fig. 1A and SI Appendix, Schemes 1-3). Given the potential antimetabolic activities of these compounds, we used a standard Alamar Blue assay to assess the combined effects of proliferation and metabolism on total cellular respiration. Using this assay, we evaluated the acute cytotoxic activities of (2′S)-2′-deoxy-2′-Cmethyl-5-ethynyluridine (Me-ara-EdU), 1-β-D-arabino-pentofuranosyl-5-ethynyluracil (ara-EU), F-ara-EdU, and EdU in human cervical cancer cells (HeLa), mouse embryonic fibroblasts (3T3), and African green monkey epithelial kidney cells (Vero). After After washing and fixing the cells, ethynyl-modified DNA was stained using AlexaFluor 488 azide and Cu(I), and total cellular DNA was stained with DAPI. Negative controls received identical treatments, but were not exposed to a synthetic nucleoside. (Scale bar: 50 μm.) 24 h, relatively little impact on total cellular respiration was observed (SI Appendix, Fig. S1 ). After 72 h of incubation, however, EdU was a potent inhibitor with IC 50 values ranging from 1 (3T3) to 10 μM (Vero) (Fig. 1B and SI Appendix, Fig. S1 ). Its delayed impact on respiration is consistent with cell-cycle arrest as the primary inhibitory mechanism of EdU (22) . Me-ara-EdU, ara-EU, and F-ara-EdU, in contrast, exhibited very little, if any, acute inhibition of cellular respiration even at concentrations of 1 mM for 72 h (Fig. 1B and SI Appendix, Fig. S1 ). These results confirmed our hypothesis that synthetic modification of the 2′-arabino position can dramatically reduce the antimetabolic activities of alkynecontaining nucleosides. To evaluate changes in cellular proliferation, HeLa cells were grown in the presence of variable concentrations of F-ara- Fig. S2 ). Interestingly, no changes in the rates of cell division were observed in tissues cultivated in 100 nM of F-ara-EdU (SI Appendix, Fig. S2 ), despite the presence of detectable DNA labeling at this concentration (Fig. 2) .
Metabolic Incorporation and DNA Labeling. To examine the potential abilities of Me-ara-EdU, ara-EU, and F-ara-EdU to be metabolically phosphorylated and incorporated into DNA, cells were incubated with variable concentrations of each nucleoside for 24 h and subsequently stained with a fluorescent azide (AlexaFluor 488) using CuAAC reactions (Fig. 1C and SI Appendix, Figs. S3-S5) . Cells initially treated with 1-100 μM of Me-ara-EdU exhibited no detectable DNA labeling (Fig. 1C and SI Appendix, Fig. S3) . The application of 100 μM ara-EU resulted in modest staining of cellular nuclei (SI Appendix, Fig. S4 ), but cells treated with 1-10 μM of ara-EU exhibited very weak or no detectable staining (Fig. 1C  and SI Appendix, Fig. S4 ). In contrast, cells initially exposed to 0.1-100 μM F-ara-EdU gave intense nuclear staining (Fig. 1C and   SI Appendix, Fig. S5 
A detailed comparison of EdU and F-ara-EdU was therefore conducted using variable nucleoside concentrations from 0.01 to 100 μM and exposure times from 24 to 72 h ( Fig. 2 and SI Appendix, Figs. S5-S7). Consistent with previous reports (13, 22) , the addition of 10 μM of EdU to live cells for 24 h followed by addition of AlexaFluor 488 azide and Cu(I) resulted in strong staining of nearly all nuclei present. Similar results were obtained for F-ara-EdU and EdU after 24 h of labeling (SI Appendix, Figs. S5 and S6) , but large differences became apparent with increased labeling times. After 72 h in the presence of 10-100 μM of EdU, mostly all of the cells had become bloated and detached from the surface due to its potent toxicity (Fig. 2) . Tissues treated with only 1 μM of EdU for 72 h were somewhat more viable and adherent, but a large fraction of these cells were either unlabeled or contained large, highly fluorescent nuclei with aberrant morphologies (Fig. 2 and SI Appendix, Fig. S7 ). In contrast, nearly all cells treated over the entire range of 0.01-10 μM of F-ara-EdU for 72 h were uniformly labeled, viable, and did not display any significant respiratory or morphological changes ( Fig. 2 and SI Appendix, Fig. S7 ). The relative staining intensities of F-ara-EdUtreated cells were roughly proportional to its applied concentrations, whereas EdU treatment resulted in strongly labeled or completely unlabeled cells after 72 h (Fig. 2 and SI Appendix, Fig. S7 ). Similar trends in metabolic incorporation were observed using HeLa (Figs. 1 and 2 ) and Vero cell cultures (SI Appendix, Fig. S8 ). No F-ara-EdU labeling could be detected in cells where DNA synthesis was selectively inhibited by aphidicoline (SI Appendix, Fig. S9 ), thus excluding the possibility of RNA incorporation.
Effects of F-ara-EdU on cell-cycle progression. EdU has previously been reported to arrest cells during the G 2 ∕M checkpoint of the cell cycle at concentrations of 100-200 nM (22) . We therefore investigated the potential ability of F-ara-EdU to initiate cellcycle arrest. After incubating HeLa cells with 1 μM of F-ara-EdU or EdU for 72 h, the cells were washed and treated with 10 μM of BrdU for an additional 24 h. The cells were then fixed and stained for alkyne groups as well as BrdU. About 90% of cells labeled with F-ara-EdU had subsequently incorporated BrdU, whereas less than 10% of EdU-treated cells had incorporated both EdU and BrdU (Fig. 3 and SI Appendix, Fig. S10 ). These data show that, unlike EdU, F-ara-EdU has very little impact on cell-cycle progression and is compatible with pulse-chase labeling strategies where continued cellular division after labeling is required.
To characterize the potential limits of F-ara-EdU in long-term labeling experiments, HeLa cells were grown with constant feeding of 1 μM of F-ara-EdU for over 60 d. Periodic CuAAC staining revealed uniformly labeled tissues, suggesting that cells did not acquire resistance to F-ara-EdU labeling. BrdU colabeling experiments further confirmed that labeled cells were not arrested in their growth cycles under these conditions (SI Appendix, Fig. S11 ). F-ara-EdU is therefore compatible with both analytical and preparative labeling of DNA where long-term tissue proliferation is required during and after metabolic labeling.
Persistence of F-ara-EdU in Labeled Chromosomes. There are a number of potential reasons for the dramatic differences between EdU and F-ara-EdU (43) . For example, F-ara-EdU might not be identified by DNA binding proteins that can detect DNA damage and cause cell arrest at the G 2 ∕M checkpoint (42) . As an alternative explanation, we were concerned that cellular DNA repair mechanisms might efficiently remove F-ara-EdU from labeled genomes, and therefore limit its utility in long-term pulse-chase experiments in vivo. To evaluate this possibility, we pulse-labeled HeLa cells with 1-10 μM of F-ara-EdU or EdU for 24 h (ca. one Fig. S12 ). Together with our data from the BrdU chase experiments (Fig. 3) , these results further demonstrate that EdU can cause irreversible cell-cycle arrest even after a relatively short pulse of only 24 h, whereas F-ara-EdU does not.
The most commonly used metabolic label, BrdU, can also be problematic in long-term pulse-chase experiments because it is known to be an efficient substrate for glycosylase-mediated repair, and it causes sister chromatid exchange mutagenesis (4). To compare the relative persistence of F-ara-EdU versus BrdU in labeled chromosomes, we pulsed HeLa cells with 10 μM of BrdU, F-araEdU, or a 1∶1 mixture of each label for 24 h. The cells were then washed to remove residual nucleosides, and "cold" chased for 48-120 h in rich media lacking synthetic nucleosides. The cells were then stained for both alkyne groups and BrdU (Fig. 4 and SI Appendix, Figs. S13 and S14). In cells receiving the 1∶1 mixture, F-ara-EdU and BrdU exhibited good colocalization after a short chase of 48 h-except in highly condensed metaphase chromosomes where F-ara-EdU was clearly superior (SI Appendix, Fig. S13 ). After 120 h, however, the number and intensity of BrdUlabeled chromosomes were significantly lower than those for F-araEdU (Fig. 4 and SI Appendix, Fig. S14 ). The persistence and sensitivity of F-ara-EdU detection in labeled chromosomes therefore exceeds BrdU. These results also suggest that F-ara-EdU provides a "pulse" that is fully compatible with a BrdU chase for birth dating of DNA in vivo. EdU, in contrast, can act as a powerful antimetabolite by inhibiting subsequent incorporation of BrdU in cell cultures and in vivo (Figs. 3 and 5C ).
Metabolic DNA Labeling in Developing Zebrafish Embryos. Zebrafish at the one-cell (zygote) stage were microinjected with F-ara-EdU and/or BrdU into the yolk sac and development was allowed to proceed for 3-5 d. We found that embryos tolerate similar amounts of F-ara-EdU and BrdU (up to ca. 3 pmol per embryo)
without showing negative effects on development or viability. Following fixation and permeabilization, the embryos injected only with BrdU exhibited strong immunostaining throughout the tail region, whereas in other body parts, such as the head, BrdU could only be visualized in the outmost cell layers (SI Appendix, Figs. S15 and S16). When stained with fluorescent azides in presence of copper(I), the embryos injected with only F-ara-EdU exhibited intense fluorescent staining throughout the entire body that colocalized with the noncovalent stain DAPI (SI Appendix, Figs. S17 and S18). F-ara-EdU labeling was detectable at amounts as low as 0.3 pmol per embryo (SI Appendix, Fig. S19 ), and uniform DNA labeling was observed in embryos as early as 5 hpf (SI Appendix, Fig. S20 ). To investigate the compatibility of F-ara-EdU and BrdU for pulse-chase experiments, Zebrafish zygotes were microinjectected with an F-ara-EdU pulse, followed by a BrdU chase at 5 hpf (end of blastula stage) or 10 hpf (end of gastrula stage). After 3 d of development, fixation and staining revealed excellent colocalization of F-ara-EdU and BrdU in larvae chased with BrdU at 5 hpf (Fig. 5A) , whereas much less colocalization was observed for larvae chased after 10 hpf (Fig. 5B) . These results are consistent with the known timing of tissue development and differentiation in Zebrafish embryos, where the first terminal divisions occur at the end of the gastrula stage (38, 39) . Interestingly, cells containing only F-ara-EdU are observed along the dorsal side of the notochord and epithelia (arrows in Fig. 5B ). These information-rich images reveal the presence and location of quiescent/senescent cells that have not divided from 10 h to 3 d after fertilization. Similar staining patterns, albeit with lower quality, are observed when BrdU is used as the pulse, followed by F-ara-EdU as the chase (SI Appendix, Fig. S21 ). Taken together, these results demonstrate the compatibility of F-ara-EdU and BrdU for birth dating of DNA in vivo. EdU pulses, in contrast, caused subsequent inhibition of BrdU incorporation in Zebrafish and therefore little colocalization was observed in vivo (Fig. 5C ).
Discussion
Visualization of DNA synthesis has traditionally been performed using BrdU, but the limited tissue permeability of anti-BrdU antibodies restricts imaging to the outermost layers of cells in whole animals (SI Appendix, Figs. S15 and S16). Small organic dyes, in contrast, are compatible with deep-tissue imaging (SI Appendix, Figs. S17 and S18). After metabolic incorporation into DNA, EdU and F-ara-EdU can be visualized in vivo with high sensitivity following click reactions with fluorescent azides (13) . This method does not require sample fixation or DNA denaturation prior to detection, and the sensitivity of EdU and F-ara-EdU detection exceed the limits of classical BrdU detection (22) . Despite these advantages, EdU is much more toxic than BrdU, and its use over prolonged experimental times results in highly nonuniform staining due to cell-cycle arrest (22) (23) (24) (25) (26) (27) . EdU is also a potent antimetabolite that inhibits subsequent incorporation of BrdU and dT into DNA (Figs. 3 and 5C , and SI Appendix, Fig. S12 ). These effects limit the utility of EdU in pulse-chase experiments and in other metabolic labeling studies where subsequent tissue survival is needed. In contrast, F-ara-EdU causes little or no cell-cycle arrest and can effectively label DNA at concentrations well below its toxicity. F-ara-EdU is therefore ideally suited for pulse-chase experiments aimed at birth dating DNA in vivo. As a demonstration of this technique, F-ara-EdU was used in an assay for identifying quiescent and senescent cells in vivo (arrows in Fig. 5 ).
In addition to enabling strategies in macromolecular engineering and drug discovery, arabinosyl nucleoside analogs can provide improved metabolic labels for applications involving bioorthogonal chemical reporter strategies. F-ara-EdU, for example, is less toxic than both BrdU and EdU, yet it can be detected with greater sensitivity under conditions of long-term growth. A comparison of each compound in terms of its toxicity versus the concentration needed for detection has revealed a much more favorable "metabolic labeling index" (analogous to therapeutic index) of F-araEdU as compared to BrdU and EdU.
The presence of a fluorine atom at the 2′-arabino position of nucleotides is known to exert a wide variety of physicochemical effects (43) . These include a strengthening of the glycosidic bond (44) that will limit F-ara-EdU's potential for catabolism. In the case of EdU, glycosidic bond hydrolysis by pyrimidine phosphorylases generates 5-ethynyluracil (45) , itself a toxic antimetabolite (46, 47) . Differences in glycosidic bond stability will also influence the relative stability of F-ara-EdU after its incorporation into DNA. Consistent with the reported behaviors of the 2′S-fluoro arabinosyl nucleoside analogs FAU and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)-5-iodouracil (48), F-ara-EdU containing chromosomes exhibit some resistance to DNA repair. This finding is consistent with previous reports that 2′S-F-substituted nucleotides are inefficient repair substrates and/or inhibitors of the enzymes responsible for DNA repair (43) . In the case of F-ara-A, the fluorine group serves to inhibit the action of cellular deaminases to dramatically increase the cellular half-life and anticancer activities of ara-A (36). This same 2-fluorine group, however, can also lead to the loss of specificity at the polymerase level as F-ara-A is incorporated into both cellular RNA and DNA, whereas ara-A (lacking fluorine) is incorporated exclusively into DNA (49) . It was therefore not clear, a priori, if 2′-arabino-modified 5-ethynyluridine derivatives would be incorporated selectively into cellular DNA, RNA, or a mixture of both. In all cases, CuAAC staining of ara-EU and F-ara-EdU-treated cells was colocalized with the noncovalent DNA probe DAPI (Figs. 1-4 ) and with BrdU ( Fig. 4 and SI Appendix, Fig. S13 ). In addition, F-ara-EdU incorporation could not be detected in cells where DNA synthesis was inhibited by aphidicoline (SI Appendix, Fig. S9 ). The specificity of F-araEdU for DNA incorporation is consistent with the presence of a stereoelectronic effect that influences sugar conformation and polymerase selectivity in vivo (50) .
Due to its minimal impact on cellular proliferation and its persistence in labeled chromosomes, F-ara-EdU will find broad applications in DNA labeling experiments. In particular, unresolved questions in developmental biology regarding the replication and flow of genetic materials over long time periods can now be addressed using this highly sensitive and minimally disruptive metabolic label for DNA.
Materials and Methods
HeLa, Vero, and 3T3 cells were cultivated at 37°C∕5% CO 2 in DMEM containing 4.5 g∕L glucose, 10% FCS, 50,000 units penicillin and 50 mg streptomycin per liter. For CuAAC staining, a freshly prepared staining mixture containing 10 μM AlexaFluor 488 azide, 1 mM CuSO 4 , and 10 mM sodium ascorbate in PBS was used. See the SI Appendix for all other experimental details and procedures. 
